JP2019516684A5 - - Google Patents

Download PDF

Info

Publication number
JP2019516684A5
JP2019516684A5 JP2018557837A JP2018557837A JP2019516684A5 JP 2019516684 A5 JP2019516684 A5 JP 2019516684A5 JP 2018557837 A JP2018557837 A JP 2018557837A JP 2018557837 A JP2018557837 A JP 2018557837A JP 2019516684 A5 JP2019516684 A5 JP 2019516684A5
Authority
JP
Japan
Prior art keywords
compound
day
weight
pharmaceutically acceptable
pharmaceutical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2018557837A
Other languages
English (en)
Japanese (ja)
Other versions
JP7145080B2 (ja
JP2019516684A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2017/031142 external-priority patent/WO2017192905A1/en
Publication of JP2019516684A publication Critical patent/JP2019516684A/ja
Publication of JP2019516684A5 publication Critical patent/JP2019516684A5/ja
Priority to JP2022147751A priority Critical patent/JP7586868B2/ja
Application granted granted Critical
Publication of JP7145080B2 publication Critical patent/JP7145080B2/ja
Priority to JP2024195175A priority patent/JP2025026895A/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2018557837A 2016-05-04 2017-05-04 重水素化jak阻害剤による脱毛障害の処置 Active JP7145080B2 (ja)

Priority Applications (2)

Application Number Priority Date Filing Date Title
JP2022147751A JP7586868B2 (ja) 2016-05-04 2022-09-16 重水素化jak阻害剤による脱毛障害の処置
JP2024195175A JP2025026895A (ja) 2016-05-04 2024-11-07 重水素化jak阻害剤による脱毛障害の処置

Applications Claiming Priority (15)

Application Number Priority Date Filing Date Title
US201662331827P 2016-05-04 2016-05-04
US62/331,827 2016-05-04
US201662338869P 2016-05-19 2016-05-19
US62/338,869 2016-05-19
US201662418774P 2016-11-07 2016-11-07
US62/418,774 2016-11-07
US201662419237P 2016-11-08 2016-11-08
US62/419,237 2016-11-08
US201662434404P 2016-12-14 2016-12-14
US62/434,404 2016-12-14
US201762466358P 2017-03-02 2017-03-02
US62/466,358 2017-03-02
US201762492758P 2017-05-01 2017-05-01
US62/492,758 2017-05-01
PCT/US2017/031142 WO2017192905A1 (en) 2016-05-04 2017-05-04 Treatment of hair loss disorders with deuterated jak inhibitors

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2022147751A Division JP7586868B2 (ja) 2016-05-04 2022-09-16 重水素化jak阻害剤による脱毛障害の処置

Publications (3)

Publication Number Publication Date
JP2019516684A JP2019516684A (ja) 2019-06-20
JP2019516684A5 true JP2019516684A5 (OSRAM) 2020-06-18
JP7145080B2 JP7145080B2 (ja) 2022-09-30

Family

ID=60203616

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2018557837A Active JP7145080B2 (ja) 2016-05-04 2017-05-04 重水素化jak阻害剤による脱毛障害の処置
JP2022147751A Active JP7586868B2 (ja) 2016-05-04 2022-09-16 重水素化jak阻害剤による脱毛障害の処置
JP2024195175A Pending JP2025026895A (ja) 2016-05-04 2024-11-07 重水素化jak阻害剤による脱毛障害の処置

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2022147751A Active JP7586868B2 (ja) 2016-05-04 2022-09-16 重水素化jak阻害剤による脱毛障害の処置
JP2024195175A Pending JP2025026895A (ja) 2016-05-04 2024-11-07 重水素化jak阻害剤による脱毛障害の処置

Country Status (21)

Country Link
US (3) US10561659B2 (OSRAM)
EP (2) EP4424367A3 (OSRAM)
JP (3) JP7145080B2 (OSRAM)
KR (3) KR20250070139A (OSRAM)
CN (1) CN109069493A (OSRAM)
AU (3) AU2017261286B2 (OSRAM)
BR (1) BR112018072339A2 (OSRAM)
CA (1) CA3022519A1 (OSRAM)
DK (1) DK3452039T3 (OSRAM)
ES (1) ES2988629T3 (OSRAM)
FI (1) FI3452039T3 (OSRAM)
HR (1) HRP20241345T1 (OSRAM)
HU (1) HUE068643T2 (OSRAM)
LT (1) LT3452039T (OSRAM)
MX (6) MX388054B (OSRAM)
PL (1) PL3452039T3 (OSRAM)
PT (1) PT3452039T (OSRAM)
RS (1) RS66006B1 (OSRAM)
SI (1) SI3452039T1 (OSRAM)
SM (1) SMT202400389T1 (OSRAM)
WO (1) WO2017192905A1 (OSRAM)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4424367A3 (en) 2016-05-04 2024-11-13 Sun Pharmaceutical Industries, Inc. Treatment of hair loss disorders with deuterated jak inhibitors
CN113906032A (zh) * 2019-02-06 2022-01-07 康塞特医药品有限公司 用于制备对映异构体富集的jak抑制剂的方法
WO2021236139A1 (en) 2020-05-21 2021-11-25 Concert Pharmaceuticals, Inc. Novel deuterated jak inhibitor and uses thereof
KR20230093504A (ko) * 2020-10-28 2023-06-27 썬 파마슈티칼 인더스트리즈 인코포레이티드 중수소화된 jak 억제제를 이용한 탈모 장애의 치료를 위한 요법
CN116916927A (zh) * 2020-10-28 2023-10-20 太阳医药工业公司 用于用氘化jak抑制剂治疗脱发症的方案
CN112402615A (zh) * 2020-11-11 2021-02-26 长沙晶易医药科技有限公司 一种用于治疗斑秃的复方外用制剂及其制备方法
CA3228505A1 (en) * 2021-08-11 2023-02-16 Sun Pharmaceutical Industries, Inc. Treatment of hair loss disorders with deuterated jak inhibitors
AU2022328282A1 (en) 2021-08-12 2024-02-22 Sun Pharmaceutical Industries, Inc. Treatment of jak-inhibition-responsive disorders with prodrugs of jak inhibitors
CN119255806A (zh) 2022-05-04 2025-01-03 太阳医药工业公司 用于用氘化jak抑制剂进行治疗的剂量方案
US12364699B2 (en) * 2023-10-10 2025-07-22 Sun Pharmaceuticals Industries, Inc. Method of treating hair loss disorders
US12247034B1 (en) * 2024-04-19 2025-03-11 Sun Pharmaceutical Industries, Inc. Crystalline form of deuruxolitinib phosphate

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9925962D0 (en) 1999-11-02 1999-12-29 Novartis Ag Organic compounds
RS83503A (sr) 2001-05-03 2006-10-27 F. Hoffmann-La Roche Ag. Farmaceutska doza amorfnog nelfinavir mezilata
WO2006039237A1 (en) 2004-09-29 2006-04-13 Cordis Corporation Pharmaceutical dosage forms of stable amorphous rapamycin like compounds
ATE525374T1 (de) 2005-12-13 2011-10-15 Incyte Corp Heteroarylsubstituierte pyrroloä2,3-büpyridine und pyrroloä2,3-büpyrimidine als januskinaseinhibitoren
CA2635581C (en) 2005-12-28 2017-02-28 Vertex Pharmaceuticals Incorporated Solid forms of n-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide
CL2008001709A1 (es) 2007-06-13 2008-11-03 Incyte Corp Compuestos derivados de pirrolo [2,3-b]pirimidina, moduladores de quinasas jak; composicion farmaceutica; y uso en el tratamiento de enfermedades tales como cancer, psoriasis, artritis reumatoide, entre otras.
JOP20190231A1 (ar) 2009-01-15 2017-06-16 Incyte Corp طرق لاصلاح مثبطات انزيم jak و المركبات الوسيطة المتعلقة به
US9198911B2 (en) 2010-11-02 2015-12-01 The Trustees Of Columbia University In The City Of New York Methods for treating hair loss disorders
HRP20191548T1 (hr) * 2010-11-02 2020-02-21 The Trustees Of Columbia University In The City Of New York Postupci liječenja poremećaja gubitka kose
EP3459565A1 (en) 2012-03-29 2019-03-27 The Trustees of Columbia University in the City of New York Methods for treating hair loss disorders
PT3882249T (pt) 2012-06-15 2025-08-06 Sun Pharmaceutical Ind Inc Derivados deuterados de ruxolitinib
AU2013296627C9 (en) * 2012-07-30 2018-03-22 Concert Pharmaceuticals, Inc. Deuterated ibrutinib
RS62329B1 (sr) 2012-11-15 2021-10-29 Incyte Holdings Corp Dozni oblici ruksolitiniba sa produženim vremenom oslobađanja
JP6367545B2 (ja) 2013-12-17 2018-08-01 コンサート ファーマシューティカルズ インコーポレイテッド ルキソリチニブの重水素化誘導体
CN110229159B (zh) * 2013-12-18 2021-08-24 康塞特医药品有限公司 卢索替尼的氘代衍生物
EA201691582A1 (ru) 2014-02-07 2017-01-30 Оспекс Фармасьютикалз, Инк. Новые фармацевтические препараты
EP4424367A3 (en) 2016-05-04 2024-11-13 Sun Pharmaceutical Industries, Inc. Treatment of hair loss disorders with deuterated jak inhibitors

Similar Documents

Publication Publication Date Title
JP2019516684A5 (OSRAM)
JP2018534348A5 (OSRAM)
RU2018114447A (ru) Введение дейтерированных усилителей cftr
JP2022009090A5 (OSRAM)
HRP20241345T1 (hr) Liječenje poremećaja gubitka kose deuteriranim inhibitorima jak
JP2013507415A5 (OSRAM)
JP2009514874A5 (OSRAM)
CN101678035A (zh) 用于治疗糖尿病的选择性雄激素受体调节剂
JP2020097577A5 (OSRAM)
WO2011160136A3 (en) Progesterone containing oral dosage forms and related methods
JP2013529665A5 (OSRAM)
WO2013022783A3 (en) Progesterone containing oral dosage forms and related methods
JP2013545752A5 (OSRAM)
JP2016515628A5 (OSRAM)
RU2017112308A (ru) Композиции и способы для лечения бессонницы
JP2013532729A5 (OSRAM)
JP2018090566A5 (OSRAM)
JP2012502103A5 (OSRAM)
JP2013519705A5 (OSRAM)
JP2021509395A5 (OSRAM)
JP2014521641A5 (OSRAM)
HRP20170564T1 (hr) Derivati aminociklobutana, metoda njihove priprave i njihova upotreba za lijekove
JP2020523317A5 (OSRAM)
JP2020510027A5 (OSRAM)
CN101816792A (zh) 包含埃坡霉素的组合及其药学用途